Necrotising autoimmune myopathy: a differential diagnosis for deranged liver function tests

William Luu, Joanne Sy and Queenie Luu
Med J Aust 2022; 217 (1): . || doi: 10.5694/mja2.51609
Published online: 4 July 2022


  • 1 University of Sydney, Sydney, NSW
  • 2 Royal Prince Alfred Hospital, Sydney, NSW
  • 3 Canterbury Hospital, Sydney, NSW


Competing interests:

No relevant disclosures.

  • 1. Luu Q, Day J, Hall A, et al. External validation and evaluation of adding MRI or extended myositis antibody panel to the 2017 EULAR/ACR myositis classification criteria. ACR Open Rheumatol 2019; 1: 462‐468.
  • 2. Pinal‐Fernandez I, Casal‐Dominguez M, Mammen AL. Immune‐mediated necrotizing myopathy. Current Rheumatol Rep 2018; 20: 21.
  • 3. Suzuki S, Nishikawa A, Kuwana M, et al. Inflammatory myopathy with anti‐signal recognition particle antibodies: case series of 100 patients. Orphanet J Rare Dis 2015; 10: 61.
  • 4. Liang C, Needham M. Necrotizing autoimmune myopathy. Curr Opin Rheumatol 2011; 23: 612‐619.
  • 5. Aggarwal R, Oddis CV, Goudeau D, et al. Anti‐signal recognition particle autoantibody ELISA validation and clinical associations. Rheumatology 2015; 54: 1194‐1199.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.